help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on June 7, 2004, doi:10.1164/rccm.200401-095OC

Am. J. Respir. Crit. Care Med., Volume 170, Number 5, September 2004, 561-566

A more recent version of this article appeared on September 1, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200401-095OCv1
170/5/561    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jasmer, R. M
Right arrow Articles by Daley, C. L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jasmer, R. M
Right arrow Articles by Daley, C. L

Submitted on January 22, 2004
Accepted on June 3, 2004

Tuberculosis Treatment Outcomes: Directly Observed Therapy Compared with Self-administered Therapy

Robert M Jasmer1*, Christopher B Seaman1, Leah C Gonzalez1, L. Masae Kawamura2, Dennis H Osmond3, and Charles L Daley4

1 Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, San Francisco, CA, USA; Department of Medicine, University of California San Francisco, San Francisco, CA, USA, 2 Francis J. Curry National Tuberculosis Center, San Francisco, CA, USA; Tuberculosis Control Section, San Francisco Department of Public Health, San Francisco, CA, USA, 3 Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA, 4 Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, San Francisco, CA, USA; Department of Medicine, University of California San Francisco, San Francisco, CA, USA; Francis J. Curry National Tuberculosis Center, San Francisco, CA, USA

* To whom correspondence should be addressed. E-mail: rjasmer{at}itsa.ucsf.edu.

Effective treatment of tuberculosis requires adherence to a minimum of six months treatment with multiple drugs. To improve adherence and cure rates, directly observed therapy is recommended for the treatment of pulmonary tuberculosis. We compared treatment outcomes among all culture-positive patients treated for active pulmonary tuberculosis (n=372) in San Francisco County, California from 1998 through 2000. Patients treated by directly observed therapy at the start of therapy (n=149) had a significantly higher cure rate compared with patients treated by self-administered therapy (n=223) (the sum of bacteriologic cure and completion of treatment, 97.8% vs. 88.6%, p<0.002), and decreased tuberculosis-related mortality (0% vs.5.5%, p=0.002). Rates of treatment failure, relapse, and acquired drug resistance were similar between the two groups. Forty-four percent of patients who received self-administered therapy had risk factors for non-adherence and should have been assigned to directly observed therapy. We conclude that treatment plans that emphasize directly observed therapy from the start of therapy have the greatest success in improving tuberculosis treatment outcomes.


Key words: pulmonary tuberculosis, directly observed therapy




This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
W. Lew, M. Pai, O. Oxlade, D. Martin, and D. Menzies
Initial Drug Resistance and Tuberculosis Treatment Outcomes: Systematic Review and Meta-analysis
Ann Intern Med, July 15, 2008; 149(2): 123 - 134.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
K. Khan, A. Campbell, T. Wallington, and M. Gardam
The impact of physician training and experience on the survival of patients with active tuberculosis.
Can. Med. Assoc. J., September 26, 2006; 175(7): 749 - 753.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
P. Nahid, M. Pai, and P. C. Hopewell
Advances in the diagnosis and treatment of tuberculosis.
Proceedings of the ATS, January 1, 2006; 3(1): 103 - 110.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
L. B. Reichman and B. T. Mangura
And The Beat Goes On
Am. J. Respir. Crit. Care Med., July 1, 2005; 172(1): 140 - 140.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. M. Jasmer, L. M. Kawamura, and C. L. Daley
And The Beat Goes On
Am. J. Respir. Crit. Care Med., July 1, 2005; 172(1): 140 - 140.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
B. Nemery, W. W. Yew, R. Albert, C. Brun-Buisson, W. MacNee, F. J. Martinez, D. C. Angus, and E. Abraham
Tuberculosis, Nontuberculous Lung Infection, Pleural Disorders, Pulmonary Function, Respiratory Muscles, Occupational Lung Disease, Pulmonary Infections, and Social Issues in AJRCCM in 2004
Am. J. Respir. Crit. Care Med., March 15, 2005; 171(6): 554 - 562.
[Full Text] [PDF]


Home page
JWatch Infect. DiseasesHome page
DOT for TB: Is It for Everyone?
Journal Watch Infectious Diseases, October 8, 2004; 2004(1008): 6 - 6.
[Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
W. J. Burman and R. R. Reves
How Much Directly Observed Therapy Is Enough?
Am. J. Respir. Crit. Care Med., September 1, 2004; 170(5): 474 - 475.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2004 American Thoracic Society
  ATS Par News